Back to Search
MICHAEL LIEVENS, MD
MD
Gastroenterology Physician
NPI: 1225038029IndividualAccepts Medicare
Specialties, Licenses & Credentials
Gastroenterology PhysicianPrimary
Internal Medicine — Gastroenterology
Code: 207RG0100X
04-27463(KS)
Education
NORTHWESTERN UNIVERSITY FEINBERG MEDICAL SCHOOL
Class of 1989
Research & Publications (19)
Evaluation of RTS,S/AS02A and RTS,S/AS01B in adults in a high malaria transmission area.
PMID 19649245·PLoS One·2009
3-trial
Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection.
PMID 19569965·J Infect Dis·2009
3-trial
Long-term safety and efficacy of the RTS,S/AS02A malaria vaccine in Mozambican children.
PMID 19569964·J Infect Dis·2009
3-trial
Development and technical and clinical validation of a quantitative enzyme-linked immunosorbent assay for the detection of human antibodies to hepatitis B surface antigen in recipients of recombinant hepatitis B virus vaccine.
PMID 19553553·Clin Vaccine Immunol·2009
4-observational
Response to "Poor control vaccines in two randomised trials of malaria vaccine?".
PMID 19486956·Vaccine·2009
8-other
Insights into long-lasting protection induced by RTS,S/AS02A malaria vaccine: further results from a phase IIb trial in Mozambican children.
PMID 19365567·PLoS One·2009
3-trial
Five-year safety and immunogenicity of GlaxoSmithKline's candidate malaria vaccine RTS,S/AS02 following administration to semi-immune adult men living in a malaria-endemic region of The Gambia.
PMID 19276646·Hum Vaccin·2009
4-observational
Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age.
PMID 19064627·N Engl J Med·2008
3-trial
Safety and immunogenicity of RTS,S/AS02D malaria vaccine in infants.
PMID 19064623·N Engl J Med·2008
3-trial
Malaria treatment with atovaquone-proguanil in malaria-immune adults: implications for malaria intervention trials and for pre-exposure prophylaxis of malaria.
PMID 18268090·Antimicrob Agents Chemother·2008
2-rct
Safety of the RTS,S/AS02A malaria vaccine in Mozambican children during a Phase IIb trial.
PMID 18069097·Vaccine·2008
3-trial
Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial.
PMID 17949807·Lancet·2007
3-trial
Evaluation of two formulations of adjuvanted RTS, S malaria vaccine in children aged 3 to 5 years living in a malaria-endemic region of Mozambique: a Phase I/IIb randomized double-blind bridging trial.
PMID 17386091·Trials·2007
8-other
RTS,S/AS02A malaria vaccine does not induce parasite CSP T cell epitope selection and reduces multiplicity of infection.
PMID 16871327·PLoS Clin Trials·2006
8-other
Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial.
PMID 16338450·Lancet·2005
2-rct
Immunogenicity and safety of an adjuvanted hepatitis B vaccine in pre-hemodialysis and hemodialysis patients.
PMID 16221232·Kidney Int·2005
2-rct
Safety and immunogenicity profile of an experimental hepatitis B vaccine adjuvanted with AS04.
PMID 15530674·Vaccine·2004
3-trial
Hepatitis A vaccine: indirect evidence of immune memory 12 years after the primary course.
PMID 14695659·J Med Virol·2004
8-other
Immunogenicity of Twinrix in older adults: a critical analysis.
PMID 12901592·Expert Rev Vaccines·2003
1-meta
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3121 N WEBB RD
WICHITA, KS 67226 - Phone
- (316) 261-3130
Quick Facts
- NPI
- 1225038029
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 37
- Publications
- 19
Are you this provider?
Claim Your Profile